SBFM Q4 2018 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$111,843+232.9% YoY

Gross Profit

$14,47712.9% margin

Operating Income

-$149,135-133.3% margin

Net Income

-$338,655-302.8% margin

EPS (Diluted)

$-3.93

QoQ Revenue Growth

-18.3%

Cash Flow

Operating Cash Flow

-$116,047

Free Cash Flow

-$107,527

Stock-Based Comp.

$75,800

Balance Sheet

Total Assets

$1M

Total Liabilities

$1M

Stockholders' Equity

-$55,753

Cash & Equivalents

$115,216

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$111,843	$33,600	+232.9%
Gross Profit	$14,477	$16,800	-13.8%
Operating Income	-$149,135	-$162,177	+8.0%
Net Income	-$338,655	-$211,479	-60.1%